GraftAssure™ technology adoption further broadens with 20 global transplant centers engaged by year-end 2025, including first Canadian ...

Rad AI announced its latest speech recognition technology that it says will improve the speed and accuracy of diagnostic reporting. The new capabilities will be embedded directly into clinicians’ ...

Some batteries that power a popular brand of e-bike pose a fire hazard that can cause serious injury or death and shouldn't be used, the Consumer Product Safety Commission (CPSC) said in a notice ...

DENVER — Federal regulators urged e-bike owners on Monday to stop using a specific type of lithium ion battery sold by Rad Power Bikes, but stopped short of issuing a recall for the battery. The ...

A federal watchdog said two models of batteries found in Rad Power Bikes should be immediately, and safely, disposed of. The bike company disputes the safety agency’s findings. By Alexandra E. Petri A ...

Rad Power Bikes, one of the most well-known electric bicycle companies in North America, appears to be headed for collapse as troubling signs have continued to stack up. The Seattle, Washington-based ...

Rad Power Bikes has informed its employees that it will shut down in January if it is unable to find new funding or get acquired, according to an internal staff email viewed by TechCrunch. The company ...

It may be the end of the road for Rad Power Bikes. The beloved Seattle e-bike maker notified the Washington State Employment Security Department that it may need to shut down in January if it can’t ...

GeekWire chronicles the Pacific Northwest startup scene. Sign up for our weekly startup newsletter, and check out the GeekWire funding tracker and VC directory. by Kurt Schlosser on Nov 10, 2025 at 12 ...

On October 29, 2025, Bio-Rad Laboratories reported third-quarter earnings with sales of US$653 million and a net loss of US$341.9 million, while also completing a major share repurchase and announcing ...

The market didn't react positively to the diagnostics specialist's third-quarter earnings report. It beat on both the top and bottom lines, but growth rates were low. Bio-Rad's Q3 saw the company book ...